Interleukin-2 [IL-2] clinical trials

The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.

This study investigates how a low dose of a medication called Interleukin-2 (IL-2) affects immune cells in fatty plaques in the neck arteries of people undergoing surgery for these plaques. Researchers want to see if IL-2 can make these cells less inflammatory and improve health.